Product Code: VMR11210617
Value Market Research deeply researched the Global Scopolamine Market to foresee a significant growth in the industry over the upcoming years. The global scopolamine market report provides a complete industry analysis, market size, market share, growth trends, and forecasts for 2023 to 2028. The report starts with a detailed market introduction and an executive summary that highlights the report's key growth numbers. The subsequent chapters discuss the value chain of the market, Porter's Five Forces Model, and market attractiveness analysis. An exclusive chapter on COVID-19 impact analysis has been added to understand how the market has responded to the pandemic.
The market dynamics section of the report elaborates the current market drivers, restraints along with the challenges/risks and upcoming opportunities. This section can be of high interest for any company's strategists and new product development department. The global scopolamine market study segments the market and provides the market size in terms of revenue and/ or sales. This data is bifurcated by region and later by countries. The data is collected through detailed primary interviews and industry experts across the world. The detailed methodology can be seen in our sample reports. These market estimates are also influenced by the latest social, political and economic changes along with the current market dynamics that are affecting this scopolamine market.
The next sections of the scopolamine market report studies the market competitiveness and profiles some key market players/manufacturers. These sections are knowledgeable for understanding the competitor's product-line, their financials, recent developments and the top market share owners in the industry.
Countries Covered in the report are as below:
North America - United States, Canada, and Mexico
Europe - United Kingdom, Germany, France, Italy, Russia, Spain & Rest of Europe
Asia-Pacific - China, India, Japan, South Korea, Australia & Rest of APAC
Latin America - Brazil, Argentina, Peru, Chile & Rest of Latin America
Middle East and Africa - Saudi Arabia, UAE, Israel, South Africa
Market Segmentation in the report is as below-
By Dosage Form
Tablet
Syrup
Injection
Patch
Others
By Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
TABLE OF CONTENTS
1 . PREFACE
- 1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
- 1.2. Research Scope
- 1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
- 2.1. Highlights of Scopolamine Market
- 2.2. Global Scopolamine Market Snapshot
3 . SCOPOLAMINE - INDUSTRY ANALYSIS
- 3.1. Introduction
- 3.2. Market Drivers of Scopolamine Market
- 3.3. Market Restraints of Scopolamine Market
- 3.4. Opportunities of Scopolamine Market
- 3.5. Trends of Scopolamine Market
- 3.6. Porter's Five Force Analysis of Scopolamine Market
- 3.7. Scopolamine Market Attractiveness Analysis
- 3.7.1 Market Attractive Analysis by Dosage Form
- 3.7.2 Market Attractive Analysis by Distribution Channel
- 3.7.3 Market Attractive Analysis by Region
4 . VALUE CHAIN ANALYSIS
- 4.1. Scopolamine Value Chain Analysis
- 4.2. Scopolamine Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Scopolamine Raw Material Manufactures List
- 4.2.3. Price Trend of Scopolamine Key Raw Materials
- 4.3. List of Potential Buyers
- 4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend
5 IMPACT ANALYSIS OF COVID-19 OUTBREAK
- 5.1. Impact Analysis of Covid-19 Outbreak on Scopolamine Market
- 5.1.1. Direct Impact on Production
- 5.1.2. Supply Chain and Market Disruption
- 5.1.3. Financial Impact on Firms and Financial Markets
- 5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
- 5.3. Scopolamine Market: Pre V/S Post COVID-19
- 5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Scopolamine Market Size in 2020, by Scenario
- 5.5. COVID-19: Micro and Macro Factor Analysis on Scopolamine Market
6 . GLOBAL SCOPOLAMINE MARKET ANALYSIS BY DOSAGE FORM
- 6.1 Overview by Dosage Form
- 6.2 Historical Data 2015-2018
- 6.3 Global Scopolamine Market Analysis by Dosage Form
- 6.4 Market Analysis of Tablet by Regions
- 6.6 Market Analysis of Syrup by Regions
- 6.5 Market Analysis of Injection by Regions
- 6.7 Market Analysis of Patch by Regions
- 6.8 Market Analysis of Others by Regions
7 . GLOBAL SCOPOLAMINE MARKET ANALYSIS BY DISTRIBUTION CHANNEL
- 7.1 Overview by Distribution Channel
- 7.2 Historical Data 2015-2018
- 7.3 Global Scopolamine Market Analysis by Distribution Channel
- 7.4 Market Analysis of Hospital Pharmacies by Regions
- 7.5 Market Analysis of Retail Pharmacies by Regions
- 7.6 Market Analysis of Online Pharmacies by Regions
8 . GLOBAL SCOPOLAMINE MARKET ANALYSIS BY GEOGRAPHY
- 8.1. Regional Outlook
- 8.2. Introduction
- 8.3. North America
- 8.3.1. Overview and Historic Data
- 8.3.2. North America Scopolamine Market Estimate By Market Segment
- 8.3.3. North America Scopolamine Market Estimate By Country
- 8.3.4. United State
- 8.3.5. Canada
- 8.3.6. Mexico
- 8.4. Europe
- 8.4.1. Overview and Historic Data
- 8.4.2. Europe Scopolamine Market Estimate by Market Segment
- 8.4.3. Europe Scopolamine Market Estimate by Country
- 8.4.4. United Kingdom
- 8.4.5. France
- 8.4.6. Germany
- 8.4.7. Italy
- 8.4.8. Russia
- 8.4.9. Rest Of Europe
- 8.5. Asia Pacific
- 8.5.1. Overview and Historic Data
- 8.5.2. Asia Pacific Scopolamine Market Estimate by Market Segment
- 8.5.3. Asia Pacific Scopolamine Market Estimate by Country
- 8.5.4. China
- 8.5.5. India
- 8.5.6. Japan
- 8.5.7. South Korea
- 8.5.8. Australia
- 8.5.9. Rest Of Asia Pacific
- 8.6. Latin America
- 8.6.1. Overview and Historic Data
- 8.6.2. Latin America Scopolamine Market Estimate by Market Segment
- 8.6.3. Latin America Scopolamine Market Estimate by Country
- 8.6.4. Brazil
- 8.6.5. Argentina
- 8.6.6. Peru
- 8.6.7. Chile
- 8.6.8. Rest of Latin America
- 8.7. Middle East & Africa
- 8.7.1. Overview and Historic Data
- 8.7.2. Middle East & Africa Scopolamine Market Estimate by Market Segment
- 8.7.3. Middle East & Africa Scopolamine Market Estimate by Country
- 8.7.4. Saudi Arabia
- 8.7.5. UAE
- 8.7.6. Israel
- 8.7.7. South Africa
- 8.7.8. Rest Of Middle East And Africa
9 . COMPETITIVE LANDSCAPE OF THE SCOPOLAMINE COMPANIES
- 9.1. Scopolamine Market Competition
- 9.2. Partnership/Collaboration/Agreement
- 9.3. Merger And Acquisitions
- 9.4. New Product Launch
- 9.5. Other Developments
10 . COMPANY PROFILES OF SCOPOLAMINE INDUSTRY
- 10.1. Company Share Analysis
- 10.2. Market Concentration Rate
- 10.3. Alchem International
- 10.3.1. Company Overview
- 10.3.2. Financials
- 10.3.3. Products
- 10.3.4. Recent Developments
- 10.4. Alkaloids of Australia
- 10.4.1. Company Overview
- 10.4.2. Financials
- 10.4.3. Products
- 10.4.4. Recent Developments
- 10.5. Baxter International Inc.
- 10.5.1. Company Overview
- 10.5.2. Financials
- 10.5.3. Products
- 10.5.4. Recent Developments
- 10.6. Caleb Pharmaceuticals, Inc.
- 10.6.1. Company Overview
- 10.6.2. Financials
- 10.6.3. Products
- 10.6.4. Recent Developments
- 10.7. Centroflora-Cms
- 10.7.1. Company Overview
- 10.7.2. Financials
- 10.7.3. Products
- 10.7.4. Recent Developments
- 10.8. Fine Chemicals Corporation
- 10.8.1. Company Overview
- 10.8.2. Financials
- 10.8.3. Products
- 10.8.4. Recent Developments
- 10.9. GlaxoSmithKline plc
- 10.9.1. Company Overview
- 10.9.2. Financials
- 10.9.3. Products
- 10.9.4. Recent Developments
- 10.10. Myungmoon Pharma Co. LTD.
- 10.10.1. Company Overview
- 10.10.2. Financials
- 10.10.3. Products
- 10.10.4. Recent Developments
- 10.11. Novartis AG
- 10.11.1. Company Overview
- 10.11.2. Financials
- 10.11.3. Products
- 10.11.4. Recent Developments
- 10.12. Perrigo Company plc
- 10.12.1. Company Overview
- 10.12.2. Financials
- 10.12.3. Products
- 10.12.4. Recent Developments
- 10.13. Phytex Australia
- 10.13.1. Company Overview
- 10.13.2. Financials
- 10.13.3. Products
- 10.13.4. Recent Developments
Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies